CHILDREN'S ALLEGRA ORAL SUSPENSION OTC
Generic Name and Formulations:
Fexofenadine HCl 30mg/5mL; contains sodium 18mg/5mL; raspberry flavor.
Indications for CHILDREN'S ALLEGRA ORAL SUSPENSION:
Allergic rhinitis (seasonal). Chronic idiopathic urticaria.
10mL every 12 hours; max 20mL/24hrs.
<2yrs: not recommended. ≥2yrs: 5mL every 12 hours; max 10mL/24hrs.
Pregnancy (Cat.C). Nursing mothers.
Avoid concomitant aluminum- or magnesium-containing antacids.
Adults: Headache, back pain, viral infection, GI upset, sinusitis, dizziness, drowsiness. Children: cough, fever, pain, otitis media, upper respiratory tract infection.
Tabs—6; ODT—6; Susp—4oz
Endocrinology Advisor Articles
- Single Blood Sample Highly Predictive for Subsequent Diabetes Diagnosis
- Adjunctive Metformin for Insulin Resistance in T1D: A Clinical Perspective
- Effect of Fructose, Allulose on Postprandial Glucose Regulation in Type 2 Diabetes
- Sex Hormone Levels May Affect Postmenopausal Heart Disease Risk
- Menopausal Hormone Therapy Slows Cognitive Decline in Postmenopausal Women
- Diabetes Treatments
- Metformin May Decrease Colorectal Cancer Risk Among Males With Diabetes
- SGLT2 Inhibitor, GLP-1 Receptor Agonist Combination Treatment for Type 2 Diabetes: Expert Insights
- Semaglutide May Induce Weight Loss in Type 2 Diabetes Despite BMI
- FDA Clears Omnipod DASH System for Diabetes Management
- Effect of Infant Feeding Practices and Gut Microbiota on Overweight in First Year
- Empagliflozin, Linagliptin Combination Therapy vs Linagliptin Monotherapy for Type 2 Diabetes
- Cleared Blood Glucose Monitor Systems Not Always Accurate
- CDC: Obesity Prevalence Higher in Non-Metropolitan Counties
- Vascular Mortality Declining in Adults With Diabetes in the United States